Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Tragara closes Series A financing to support oncology and inflammatory programs

March 16, 2007

Nektar advances PEG-irinotecan into phase I

March 16, 2007

Curis selects CUDC-101 from targeted cancer drug development platform

March 16, 2007

Adherex outlines achievements of 2006, updates goals for 2007

March 16, 2007

Recent patents cover new therapeutic agents for cancer

March 16, 2007

Astellas Pharma updates clinical progress of YM-155

March 16, 2007

SPA agreement for phase III EOquin trials in noninvasive bladder cancer

March 15, 2007

Virax grants Transgene access to Co-X-Gene technology

March 15, 2007

Cell Therapeutics seeks SPA for pixantrone trial in indolent NHL

March 15, 2007

Phase Ib/II data on single agent ADH-1 presented

March 15, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...